---
source_pdf: "https://docs.google.com/presentation/d/1QFLoTDsYWtuZYUrcs342eOdW5grni8LH/edit?usp=drivesdk&ouid=115282597639191279335&rtpof=true&sd=true"
drive_folder: "Portfolio/Mural/Mural Health Data Room Materials"
type: portfolio
company: Mural
ingested: 2025-12-23
original_filename: "Mural Health Company Overview (8 Jan 2024) (2).pptx"
---

> **Original:** [View Original PDF](https://docs.google.com/presentation/d/1QFLoTDsYWtuZYUrcs342eOdW5grni8LH/edit?usp=drivesdk&ouid=115282597639191279335&rtpof=true&sd=true)

## Slide 2

Clinical Trial Industry: Core Problems & Associated Expense

---

## Slide 3

Mural Health’s Mission

To Make it Easier for ALL People to Participate in Clinical Research.

By eliminating barriers that Prevent Study Participation

---

## Slide 4

Platform Vision

Recruit

Pre-
Qualify

Schedule

Screen
Conversion

Consent

Participant
Expense / Financial
Management

Participant Travel

Data Collection / ePRO

Participant
Feedback

Enrollment to Study Completion

Pre-Enrollment

Participant
Logistics

Participant-Facing Protocol / Study Operation

Post-Study

Patient
Communities

Participant Journey

SupportContinued

Nurse Navigation

Meals

Childcare / Patcare

Participant
Communication

Remote Caregiver

Mental Health
Tele Health
Lab Logistics
Other/TBD

S

S

S

S

S

V

Digital

Analog

V

F

F

F

F

F

F

Compliance

Tokenization

Post-StudySupport

Study Results /Data Share

Other TBD

Pre-Study

Site Staff

S

V

Vendors / Point Solutions

F

Mural Health
Roadmap

Mural Link
Live

2024
Maybe*

A Single Platform to Manage All Participant Interactions

2024
Plan

2024
Plan

2024
Maybe*

2024 Roadmap (Existing):
- Depth in existing feature sets especially financial mgmt. and travel
- Tech infrastructure / process
- Existing feature optimization

---

## Slide 5

Market Opportunity

Multiple TAM expansion opportunities exist, with payment functionality serving as a natural wedge into other patient facing opportunities required by pharma, including: eCOA, ePRO, (TAM of $835M), EDC (TAM of $985M), patient engagement (eConsent -TAM of $500M), analytics and data integration (TAM of $1.5B), Investigator payments (TAM of $1.4B) etc

---

## Slide 6

Business Model

Mural Health provides tech to both sponsors and research sites across the spectrum of sizes / types within each segment

---

## Slide 7

Business Model: Sponsor

---

## Slide 8

Business Model: Site / University

---

## Slide 9

Traction to Date

Commercial

Select Customers

Financial

Select Logos in Pipe

Product-Market Fit Established in 6 Months across Diverse Customer Types (Large Pharma, Biotech, Medical Device, Site, CRO, University)

---

## Slide 10

Core Product Strategy Assumptions Proven

---

## Slide 11

Mural Health vs Greenphire: Whats Different

But can’t Greenphire simply follow MH? Nope…lets talk about it.

---

## Slide 12

Why are Tax Regulations Relevant?

Eliminating tax as a barrier to participation increases recruitable patients in the USA by 30%, consequently improving enrollment and retention rates

---

## Slide 13

How is Mural Health Addressing Tax Barriers

Legislative: Our bill will be introduced into Congress in Jan 2024

MH has identified an innovative operating structure that allows us to eliminate tax exposure for low-income participants (nobody has ever done this…)

The Harley Jacobsen Clinical Trial Participation Act

---

## Slide 14

Maureen Jacobsen: A Case Study

---

## Slide 15

Mural Health: An Operating System

HR

Finance

Strategy

Marketing

Product

Engineering

Customer Success

Sales

The Core

---

## Slide 16

Select Screen Shots

---

## Slide 17

Appendix

---

## Slide 18

LaunchCompany

Prod / Market Fit

Prepare to Scale

Efficient Growth ----->

Prepared to Scale with Strong Sales / Product Foundation

---

## Slide 19

Select Financial Data

---

## Slide 20

Select Financial Data (Cont.)

---

## Slide 21

Projection